About this document
HSH-123 Study for Hypertension Treatment by Dnyanesh Limaye is a document available to read on EtoBox.
This document outlines a protocol for a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of the investigational drug HSH-123 for the treatment of essential hypertension. The study will involve 400 hypertensive patients randomized to receive either HSH-123 or a placebo for 4 months at 26 centers across Germany, France, and India. The primary objective is to demonstrate the effect of HSH-123 in decreasing blood pressure and rates of cardiac defects. Secondary objectives a
- Author
- Dnyanesh Limaye
- Language
- EN